Zoe T. Duberstein

Zoe T. Duberstein

Auto-generated profile, based on publicly available information

Zoe T. Duberstein

Department of Psychology, University of Rochester , Rochester, NY

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
ZDZoe T. Duberstein
Zoe T. Duberstein
JBJessica Brunner
Jessica Brunner
LPLisa S. Panisch
Lisa S. Panisch
SBSanjukta Bandyopadhyay
Sanjukta Bandyopadhyay
CICarrie Irvine
Carrie Irvine
TOThomas G. O'COnnor
Thomas G. O'COnnor
Insufficient care in the perinatal period is associated with poorer maternal health, poorer perinatal outcomes, infant mortality, and health inequalities. Identifying the sources of and reducing the rates of insufficient care is therefore a major clinical and public health objective. We propose a specific application of the biopsychosocial model that conceptualizes prenatal and postpartum care quality as health markers that are influenced by psychological factors and family and social context. Clinic attendance data were abstracted from the electronic medical records of N = 291 participants enrolled in a longitudinal pregnancy cohort study of healthy women who have been followed since the first trimester; the Kotelchuck Index (KI) was calculated as an index of perinatal care utilization. Detailed prenatal psychological, social, and sociodemographic data were collected from self-report questionnaire and interview. Bivariate analyses indicated socio-demographic (e.g., race), psychological (e.g., response to perceived racism, affective symptoms, trauma experience), and social and family context (e.g., social support, family size) significantly influenced pre- and post-natal care utilization. Multivariate logistic regression analyses, adjusting for medical complications, identified social and family context as robust predictors of perinatal care utilization. The findings underscore the need for biopsychosocial models of health care and highlight several potential strategies for improving health care utilization.

9 March 2024 in Placenta
Verified
Journal Article
Closed access
SCSadia Firoza Chowdhury
Sadia Firoza Chowdhury
NPNashae Prout
Nashae Prout
ZRZorimar Rivera-Núñez
Zorimar Rivera-Núñez
EBEmily Barrett
Emily Barrett
JBJessica Brunner
Jessica Brunner
TOThomas G. O'COnnor
Thomas G. O'COnnor

18 April 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
MAMilla Arabadjian
Milla Arabadjian
ZDZoe T. Duberstein
Zoe T. Duberstein
SSSarah H. Sperber
Sarah H. Sperber
KKKiranjot Kaur
Kiranjot Kaur
JKJolaade Kalinowski
Jolaade Kalinowski
TSTanya M. Spruill
Tanya M. Spruill
Background: Psychological well‐being is important among individuals with myocardial infarction (MI) given the clear links between stress, depression, and adverse cardiovascular outcomes. Stress and depressive disorders are more prevalent in women than men after MI. Resilience may protect against stress and depressive disorders after a traumatic event. Longitudinal data are lacking in populations post MI. We examined the role of resilience in the psychological recovery of women post MI, over time. Methods and Results: We analyzed a sample from a longitudinal observational multicenter study (United States, Canada) of women post MI, between 2016 and 2020. Perceived stress (Perceived Stress Scale‐4 [PSS‐4]) and depressive symptoms (Patient Health Questionnaire‐2 [PHQ‐2]) were assessed at baseline (time of MI) and 2 months post MI. Demographics, clinical characteristics, and resilience (Brief Resilience Scale [BRS]) were collected at baseline. Low and normal/high resilience groups were established as per published cutoffs (BRS scores <3 or ≥3). Mixed‐effects modeling was used to examine associations between resilience and psychological recovery over 2 months. The sample included 449 women, mean (SD) age, 62.2 (13.2) years, of whom 61.1% identified as non‐Hispanic White, 18.5% as non‐Hispanic Black, and 15.4% as Hispanic/Latina. Twenty‐three percent had low resilience. The low resilience group had significantly higher PSS‐4 and PHQ‐2 scores than the normal/high resilience group at all time points. In adjusted models, both groups showed a decrease in PSS‐4 scores over time. Conclusions: In a diverse cohort of women post MI, higher resilience is associated with better psychological recovery over time. Future work should focus on developing strategies to strengthen resilience and improve psychological well‐being for women with MI. Registration: URL: https://clinicaltrials.gov/ct2/show/NCT02905357 ; Unique identifier: NCT02905357.

17 May 2023 in Psychosomatic Medicine
Verified
Journal Article
Closed access
LPLisa S. PhD Panisch
Lisa S. PhD Panisch
HMHannah R. Murphy
Hannah R. Murphy
QWQiuyi Bs Wu
Qiuyi Bs Wu
JBJessica L. Bs Brunner
Jessica L. Bs Brunner
ZDZoe T. Ba Duberstein
Zoe T. Ba Duberstein
TOThomas G. O’cOnnor
Thomas G. O’cOnnor
Objective: Adverse childhood experiences (ACEs) are associated with negative prenatal and perinatal health outcomes and may, via these pathways, have intergenerational effects on child health and development. We examine the impact of ACEs on maternal salivary cortisol, a key measure of prenatal biology previously linked with pregnancy-related health outcomes. Methods: Leveraging assessments across three trimesters, we used linear mixed-effects models to analyze the influence of ACEs on maternal prenatal diurnal cortisol patterns in a diverse cohort of pregnant women (analytic sample, n = 207). Covariates included comorbid prenatal depression, psychiatric medications, and sociodemographic factors. Results: Maternal ACEs were significantly associated with flatter diurnal cortisol slopes (i.e., less steep decline), after adjusting for covariates, with effects consistent across gestation (estimate = 0.15, standard error = 0.06, p = .008). Conclusions: ACEs experienced before pregnancy may have a robust and lasting influence on maternal prenatal hypothalamic-pituitary-adrenal activity throughout gestation, a key biological marker associated with perinatal and child health outcomes. The findings suggest one route of intergenerational transmission of early adverse experiences and underscore the potential value of assessing prepregnancy adverse experiences for promoting perinatal and maternal and child health.

11 March 2025 in Archives of Women's Mental Health
Verified
Journal Article
Closed access
PDF file
ZDZoe T. Duberstein
Zoe T. Duberstein
KBKeisha Bell
Keisha Bell
EPEllen Poleshuck
Ellen Poleshuck
MAMolly S. Arnold
Molly S. Arnold
SMSusan H. McDaniel
Susan H. McDaniel
TOThomas G. O’cOnnor
Thomas G. O’cOnnor

21 May 2026 in American Journal of Epidemiology
Verified
Journal Article
Open access
KHKatelyn K Huff
Katelyn K Huff
NGNoya Galai
Noya Galai
GFGarrett Fuselier
Garrett Fuselier
GWGuojing Wu
Guojing Wu
HHHadley J Hartwell
Hadley J Hartwell
RFRebecca C Fry
Rebecca C Fry
Acetaminophen is among the most common over-the-counter medications used during pregnancy. Given inconsistent findings from both experimental and epidemiological studies on associations between use and adverse health outcomes, further research is warranted. To address this, our objective was to assess the relationship between prenatal acetaminophen use and birth outcomes. We studied 8957 mother–infant pairs from 36 pediatric study sites participating in the Environmental influences on Child Health Outcomes (ECHO) program. After imputation and inverse probability weighting, we used regression models to examine the relationship between acetaminophen during pregnancy and the following outcomes: (1) preterm birth, (2) birthweight, (3) small-for-gestational age (SGA), and (4) large-for-gestational-age (LGA). Approximately 59% of mothers reported using acetaminophen at any point during their pregnancy (n = 5257). After adjustment for relevant covariates, prenatal acetaminophen use was associated with lower odds of LGA (adjusted odds ratio [aOR]: 0.87; 95% CI: 0.79, 0.96). Prenatal acetaminophen use was not associated with preterm birth (aOR: 0.99; 95% CI: 0.86, 1.14), birthweight (aβ: −7.52 g; 95% CI: −27.80, 12.77) or SGA (aOR: 1.02; 95% CI: 0.88, 1.18). Based on these findings, future research should test for dose–response, trimester-specific exposures, and factors affecting individual responses.